Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan A Lemp

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Human Immunology|January 21, 2026
HLA typing challenges in organ donation after transplantNathan A Lemp, Peter Lalli, Sara O Dionne
Nucleic Acids Research|May 24, 2012
Cryptic transcripts from a ubiquitous plasmid origin of replication confound tests for cis-regulatory functionNathan A Lemp, Kei Hiraoka, Noriyuki Kasahara, et al.
Journal of Molecular Biology|May 15, 2007
Adaptive evolution of a tagged chimeric gammaretrovirus: identification of novel cis-acting elements that modulate splicingChristopher R Logg, Brian T Baranick, Nathan A Lemp, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 11, 2008
Splicing mediates the activity of four putative cellular internal ribosome entry sitesBrian T Baranick, Nathan A Lemp, Jill Nagashima, et al.
Clinical Transplants|August 7, 2014
Immunoglobulin G subclass analysis of HLA donor specific antibodies in heart and renal transplant recipientsJames C Cicciarelli, Noriyuki Kasahara, Nathan A Lemp, et al.
Blood|February 28, 2002
Ph(+) acute lymphoblastic leukemia resistant to the tyrosine kinase inhibitor STI571 has a unique BCR-ABL gene mutationWolf-K Hofmann, Letetia C Jones, Nathan A Lemp, et al.
Journal of Immunology Research|February 10, 2017
Renal Transplant Patients Biopsied for Cause and Tested for C4d, DSA, and IgG Subclasses and C1q: Which Humoral Markers Improve Diagnosis and Outcomes?James C Cicciarelli, Nathan A Lemp, Youngil Chang, et al.
Clinical Transplants|August 7, 2014
Reduction of HLA class I expression by ribonucleic acid interference mitigates allogenicity of human primary and Immortalized cellsNathan A Lemp, Kazunori Haga, Katrin Hacke, et al.
Experimental Hematology|October 18, 2011
Combined preconditioning and in vivo chemoselection with 6-thioguanine alone achieves highly efficient reconstitution of normal hematopoiesis with HPRT-deficient bone marrowKatrin Hacke, Akos Szakmary, Andrew R Cuddihy, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Human Immunology|January 21, 2026
HLA typing challenges in organ donation after transplantNathan A Lemp, Peter Lalli, Sara O Dionne
Nucleic Acids Research|May 24, 2012
Cryptic transcripts from a ubiquitous plasmid origin of replication confound tests for cis-regulatory functionNathan A Lemp, Kei Hiraoka, Noriyuki Kasahara, et al.
Journal of Molecular Biology|May 15, 2007
Adaptive evolution of a tagged chimeric gammaretrovirus: identification of novel cis-acting elements that modulate splicingChristopher R Logg, Brian T Baranick, Nathan A Lemp, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 11, 2008
Splicing mediates the activity of four putative cellular internal ribosome entry sitesBrian T Baranick, Nathan A Lemp, Jill Nagashima, et al.
Clinical Transplants|August 7, 2014
Immunoglobulin G subclass analysis of HLA donor specific antibodies in heart and renal transplant recipientsJames C Cicciarelli, Noriyuki Kasahara, Nathan A Lemp, et al.
Blood|February 28, 2002
Ph(+) acute lymphoblastic leukemia resistant to the tyrosine kinase inhibitor STI571 has a unique BCR-ABL gene mutationWolf-K Hofmann, Letetia C Jones, Nathan A Lemp, et al.
Journal of Immunology Research|February 10, 2017
Renal Transplant Patients Biopsied for Cause and Tested for C4d, DSA, and IgG Subclasses and C1q: Which Humoral Markers Improve Diagnosis and Outcomes?James C Cicciarelli, Nathan A Lemp, Youngil Chang, et al.
Clinical Transplants|August 7, 2014
Reduction of HLA class I expression by ribonucleic acid interference mitigates allogenicity of human primary and Immortalized cellsNathan A Lemp, Kazunori Haga, Katrin Hacke, et al.
Experimental Hematology|October 18, 2011
Combined preconditioning and in vivo chemoselection with 6-thioguanine alone achieves highly efficient reconstitution of normal hematopoiesis with HPRT-deficient bone marrowKatrin Hacke, Akos Szakmary, Andrew R Cuddihy, et al.
Pageof 1